neutropenia
common
complic
patient
undergo
chemotherapi
malign
one
import
risk
factor
infect
infect
account
substanti
morbid
mortal
fever
often
indic
infect
patient
group
empir
prompt
administr
broadspectrum
antimicrobi
one
import
contribut
increas
event
free
surviv
overal
surviv
among
patient
today
bacteraemia
identifi
patient
studi
viral
contribut
aetiolog
panorama
still
limit
estim
leav
approxim
third
febril
episod
unexplain
despit
extens
microbiolog
investig
thu
term
fever
unknown
origin
fuo
cytotox
agent
administ
treatment
underli
malign
often
caus
intestin
mucos
damag
subsequ
inflamm
mucosisti
process
disrupt
balanc
normal
bowel
bacteri
flora
host
immun
system
creat
milieu
microbi
product
could
transloc
system
circul
endotoxin
specif
lipopolysaccharid
lp
found
commonli
outer
membran
gram
neg
bacteria
presenc
peripher
circulatori
system
could
thu
signifi
potenti
bacteri
invas
requir
rapid
host
respons
potent
pyrogen
endotoxin
activ
inflammatori
host
defenc
via
bind
solubl
turn
initi
downstream
cytokin
import
clearanc
bacteri
infect
elev
endotoxin
report
studi
immunocompromis
cohort
exampl
patient
haematolog
malign
use
measur
microbi
transloc
sinc
manifest
febril
state
depend
upon
proinflammatori
respons
toward
endotoxin
receptor
lp
could
suitabl
immedi
earli
respons
biomark
fever
associ
microbi
transloc
studi
thu
sought
determin
contribut
microbi
transloc
fuo
episod
adult
febril
neutropaen
cohort
use
endotoxin
concentr
plasma
marker
microbi
transloc
month
period
januari
februari
adult
patient
haematolog
disord
karolinska
univers
hospit
stockholm
inform
consent
includ
cross
section
studi
inclus
criterion
chemotherapyinduc
neutropenia
absolut
neutrophil
count
patient
develop
fever
auricular
temperatur
twice
within
hour
one
occas
sampl
within
hour
fever
onset
wherea
patient
without
fever
sampl
upon
routin
medic
appoint
neutropenia
episod
whole
blood
collect
edtatub
plasma
prepar
centrifug
storag
use
addit
blood
nasal
pharyng
aspir
npa
sampl
collect
microbiolog
test
medic
record
retrospect
acquir
includ
patient
studi
approv
region
ethic
review
board
stockholm
permit
number
patient
screen
diagnost
panel
blood
bacteri
cultur
pcr
viral
diagnost
adenoviru
epstein
barr
viru
cytomegaloviru
perform
accord
clinic
routin
local
clinic
microbiolog
laboratori
karolinska
univers
hospit
addit
viral
diagnost
bk
polyomaviru
blood
sampl
respiratori
virus
human
rhinoviru
respiratori
syncyti
viru
coronaviru
influenza
viru
b
parainfluenza
viru
metapneumoviru
parvoviru
kiwu
polyoma
viru
adenoviru
npa
sampl
perform
inhous
base
pcr
method
describ
previou
studi
ohrmalm
et
al
lp
detect
patient
plasma
endpoint
chromogen
limulu
amebocyt
lysat
lal
method
use
kit
lonza
group
ltd
switzerland
modif
visualis
cleav
substrat
reagent
consum
endotoxin
lonza
briefli
plasma
dilut
mm
solut
heat
inactiv
minut
product
cool
room
temperatur
minut
sampl
ad
empti
well
endotoxin
free
flat
bottom
plate
lonza
background
absorb
measur
nm
labsystem
multiskan
mcc
deltasoft
multiskan
iii
plate
place
block
heater
start
micropl
assay
thereaft
prewarm
lal
lysat
lonza
ad
well
incub
min
follow
pre
warm
chromogen
substrat
solut
lonza
incub
minut
reaction
stop
addit
sodium
nitrat
mgml
n
hcl
well
subsequ
ammonium
sulpham
mgml
dissolv
water
ad
well
follow
neda
n
ethylenediamin
dihydrochlorid
mgml
produc
brilliant
magentacolor
deriv
color
chang
measur
nm
within
minut
endotoxin
standard
euml
euml
prepar
endotoxin
free
water
analys
alongsid
sampl
lp
spike
sampl
control
assay
inhibit
calcul
lp
level
final
absorb
read
subtract
background
read
deriv
linear
regress
absorb
read
known
endotoxin
standard
concentr
plasma
concentr
measur
commerci
avail
quantikin
human
immunoassay
kit
r
system
inc
minneapoli
usa
absolut
neutrophil
leucocyt
count
obtain
retrospect
medic
record
routin
blood
analys
addit
absolut
count
lymphocyt
cell
cell
cd
cell
cell
monocyt
determin
episod
materi
avail
flow
cytometri
use
bd
multitest
antibodi
trucount
tube
bd
bioscienc
nj
usa
statist
analys
made
prism
suit
graphpad
inc
ca
usa
fisher
exact
test
mannwhitney
test
use
investig
patient
gener
characterist
mannwhitney
test
use
analys
involv
continu
data
two
group
kruskalw
test
use
analys
comparison
continu
data
group
requir
correl
calcul
use
spearman
rank
test
pvalu
consid
statist
signific
neutropaen
cohort
endotoxin
concentr
differ
febril
afebril
episod
figur
febril
patient
median
pgml
iqr
pgml
similar
plasma
endotoxin
concentr
afebril
patient
median
pgml
pgml
stratif
febril
episod
base
microbiolog
find
reveal
significantli
p
elev
endotoxin
concentr
fuo
episod
median
pgml
iqr
pgml
whilst
episod
document
bacteri
pgml
iqr
pgml
viral
pgml
iqr
pgml
find
similar
figur
correl
observ
viral
find
endotoxin
concentr
interestingli
use
prophylact
antibiot
ciprofloxacin
combin
therapi
trimetoprim
sulfamethoxazol
correl
higher
p
endotoxin
level
median
pgml
iqr
pgml
compar
median
pgml
iqr
pgml
episod
prophylact
antibiot
administ
figur
associ
seen
endotoxin
concentr
neither
form
antibiot
administ
sampl
underli
diseas
gener
treatment
regim
posit
associ
observ
concentr
manifest
febril
statu
p
concentr
higher
febril
episod
pgml
iqr
pgml
pgml
compar
afebril
episod
pgml
iqr
pgml
figur
stratif
febril
episod
bacteri
find
viral
find
fuo
show
signific
correl
p
figur
upon
classif
episod
bacteri
find
gramposit
bacteraemia
gramneg
bacteraemia
differ
p
observ
figur
concentr
fuo
episod
pgml
iqr
pgml
similar
gramneg
bacteraemia
pgml
iqr
pgml
whilst
gramposit
bacteria
find
observ
lower
median
concentr
pgml
iqr
pgml
correl
observ
viral
find
concentr
associ
concentr
underli
diseas
observ
endotoxin
concentr
intercorrel
cohort
similar
result
obtain
analys
limit
febril
episod
cohort
iatrogen
neutropaen
adult
found
elev
plasma
level
endotoxin
febril
neutropaen
episod
microbiolog
find
document
implic
microbi
transloc
potenti
contributor
toward
febril
statu
observ
correl
use
prophylact
antibiot
increas
plasma
endotoxin
concentr
previou
studi
attempt
determin
relat
microbi
transloc
febril
episod
similar
patient
cohort
present
mix
result
stem
primarili
differ
endotoxin
detect
method
degre
immunosuppress
patient
small
sampl
size
also
note
studi
limit
work
system
concentr
endotoxin
posit
faecal
bacteri
cultur
indic
microbi
transloc
one
studi
proinflammatori
cytokin
measur
well
howev
patient
less
immunosuppress
compar
current
studi
lead
difficulti
adequ
comparison
end
effort
place
amass
larger
studi
cohort
strict
adher
inclus
criteria
endotoxin
concentr
measur
establish
commonli
use
commerci
assay
ad
field
studi
addit
measur
plasma
endotoxin
concentr
also
measur
host
receptor
lp
attempt
determin
contribut
microbi
transloc
fever
clinic
outcom
adult
iatrogen
neutropaen
cohort
appar
correl
fever
endotoxin
concentr
observ
median
endotoxin
concentr
howev
elev
whole
cohort
compar
healthi
control
earlier
report
correspond
associ
concentr
febril
statu
suggest
host
respons
mediat
bind
lp
initi
lead
develop
fever
symptom
implic
afebril
patient
potenti
inadequ
respond
admittedli
microbiolog
find
consid
like
ground
fever
stratif
perform
teas
apart
confound
endotoxin
concentr
fuo
episod
significantli
elev
compar
episod
bacteria
find
one
might
expect
presenc
bacteria
find
blood
correl
elev
endotoxin
concentr
pertin
bear
mind
detect
target
endotoxin
assay
immunoreact
lipid
portion
lp
lower
endotoxin
concentr
observ
episod
bacteri
find
well
similar
endotoxin
concentr
episod
bacteri
viral
find
could
reflect
situat
avail
anchor
lp
molecul
bacteri
outer
membran
exposur
occur
shed
upon
disrupt
bacteri
cell
wall
thu
line
previou
studi
surpris
bacteria
find
necessarili
correl
increas
measur
endotoxin
lack
accuraci
precis
undoubtedli
limit
use
lal
assay
routin
clinic
practic
wide
use
standardis
method
measur
endotoxin
concentr
recent
year
tendenc
hydrophob
region
lipid
aggreg
bind
lp
bind
protein
could
also
potenti
limit
detect
correspond
trend
howev
observ
concentr
differ
episod
stratifi
base
microbiolog
find
lack
thereof
respect
fuo
group
concentr
episod
gram
neg
bacteria
find
higher
gram
posit
find
indic
differenti
respons
bacteria
subgroup
expect
concentr
observ
studi
similar
level
found
plasma
infect
patient
microbi
transloc
document
unlik
endotoxin
concentr
fuo
episod
higher
episod
gram
neg
bacteria
perform
dual
role
low
level
transfer
lp
initi
proinflammatori
respons
howev
high
system
concentr
act
attenu
cell
respons
shuttl
lp
lipoprotein
elev
endotoxin
observ
cohort
find
contend
could
act
inhibitori
way
limit
excess
bystand
damag
prolong
system
proinflammatori
respons
thu
despit
higher
endotoxin
concentr
fuo
group
correspond
increas
inher
immunosuppress
state
cohort
could
also
implic
satur
respons
observ
monocyt
lesser
extent
neutrophil
suggest
main
sourc
either
shed
secret
directli
antineoplast
treatment
underli
diseas
leav
patient
reduc
monocyt
neutrophil
henc
limit
product
entir
surpris
dampen
secret
could
also
explain
lack
correl
endotoxin
concentr
studi
overal
find
show
evid
microbi
transloc
particularli
fuo
episod
elev
endotoxin
concentr
anoth
interest
find
studi
use
prophylact
antibiot
associ
higher
plasma
endotoxin
concentr
liber
use
prophylact
antibiot
commonplac
iatrogen
neutropaen
patient
preemptiv
measur
bacteri
infect
highli
suscept
patient
group
yet
extens
use
oral
prophylact
antibiot
might
predispos
patient
increas
risk
microbi
transloc
subsequ
present
fever
delay
chemotherapi
cycl
underli
haematolog
malign
one
could
specul
use
prophylact
antibiot
led
excess
remnant
bacteri
product
alter
bowel
microflora
promot
overgrowth
resist
variant
correl
endotoxin
concentr
durat
prophylact
antibiot
use
would
ideal
unfortun
abl
accur
determin
paramet
studi
collect
find
suggest
patient
transloc
bacteri
product
rather
whole
bacteria
intestin
occur
correl
find
enterocyt
function
integr
could
provid
insight
possibl
mechan
transloc
consid
futur
studi
arguabl
bacteri
find
base
sole
posit
bacteri
cultur
could
lack
sensit
underestim
episod
bloodborn
bacteri
find
broad
spectrum
pcr
target
conserv
bacteri
gene
like
rdna
could
improv
bacteri
diagnost
inher
difficulti
crosscontamin
fals
posit
resolv
regardless
pcr
diagnost
viabl
option
circumv
limit
consid
futur
studi
studi
chosen
follow
convent
clinic
bacteriolog
routin
order
obtain
current
clinic
pictur
given
transient
natur
circul
endotoxin
care
taken
ensur
sampl
obtain
within
hr
window
within
sampl
bia
observ
addit
inform
regard
mucos
grade
unfortun
unavail
studi
consid
inclus
futur
studi
measur
mucos
damag
would
desir
perform
longitudin
studi
order
determin
correl
endotoxin
concentr
progress
sever
infect
even
septic
condit
unfortun
possibl
current
studi
consid
studi
patient
cohort
crosssect
studi
find
suggest
absenc
microbiolog
find
microbi
transloc
could
contribut
febril
episod
adult
neutropaen
cohort
add
repertoir
potenti
caus
fever
also
indic
urgenc
suitabl
biomark
distinguish
drug
tumour
relat
fever
dtrf
fever
infecti
caus
associ
prophylact
antibiot
use
increas
plasma
endotoxin
concentr
observ
